Connect public, paid and private patent data with Google Patents Public Datasets

Transdermales abgabesystem zur verabreichung von fentanyl

Info

Publication number
DE3526339A1
DE3526339A1 DE19853526339 DE3526339A DE3526339A1 DE 3526339 A1 DE3526339 A1 DE 3526339A1 DE 19853526339 DE19853526339 DE 19853526339 DE 3526339 A DE3526339 A DE 3526339A DE 3526339 A1 DE3526339 A1 DE 3526339A1
Authority
DE
Grant status
Application
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19853526339
Other languages
English (en)
Other versions
DE3526339C2 (de )
Inventor
Robert M Gale
Victor Goetz
Eun S Lee
Lina T Taskovich
Su Il Yum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
DE19853526339 1984-07-23 1985-07-23 Expired - Lifetime DE3526339C2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US4588580B2 US4588580B2 (en) 1984-07-23 1984-07-23 Transdermal administration of fentanyl and device therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853546830 DE3546830C2 (de) 1984-07-23 1985-07-23 Transdermales Abgabesystem zur Verabreichung von Fentanyl

Publications (2)

Publication Number Publication Date
DE3526339A1 true true DE3526339A1 (de) 1986-01-30
DE3526339C2 DE3526339C2 (de) 1992-01-09

Family

ID=24541036

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853526339 Expired - Lifetime DE3526339C2 (de) 1984-07-23 1985-07-23

Country Status (9)

Country Link
US (1) US4588580B2 (de)
JP (1) JP2547726B2 (de)
BE (2) BE902884A (de)
CA (1) CA1245983A (de)
DE (1) DE3526339C2 (de)
ES (2) ES8802276A1 (de)
FR (1) FR2567761B1 (de)
GB (1) GB2165148B (de)
NL (1) NL8501979A (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839410A1 (de) * 1987-11-23 1989-06-01 Alza Corp Mittel zur transdermalen verabreichung von wirkstoffen
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US8778382B2 (en) 2003-04-30 2014-07-15 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form

Families Citing this family (245)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4751087B1 (de) * 1985-04-19 1993-03-02 Riker Laboratories Inc
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
EP0223524B1 (de) * 1985-11-08 1991-10-23 Nitto Denko Corporation Verwendung von Heftpflastern für die Haut und perkutanen Präparaten
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
DE3775830D1 (de) * 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
ES2075966T3 (es) * 1986-12-22 1995-10-16 Cygnus Therapeutic Systems Dispositivo de suministro de medicamentos solidos que utilizan esteres de acidos grasos o eteres de alcoholes grasos de alcanodioles como potenciadores de absorcion percutanea.
CA1308655C (en) * 1986-12-22 1992-10-13 Gary W. Cleary Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US4981782A (en) * 1987-05-14 1991-01-01 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
US4853227A (en) * 1987-10-23 1989-08-01 Ciba-Geigy Corporation Transdermal administration of a systemic active agent to a premature neonatal infant
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US5925372A (en) * 1987-12-16 1999-07-20 Novartis Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US4891377A (en) * 1988-12-02 1990-01-02 Board Of Regents Acting For And On Behalf Of University Of Michigan Transdermal delivery of the narcotic analgesics etorphine and analogs
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5064654A (en) * 1989-01-11 1991-11-12 Ciba-Geigy Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
WO1993007870A1 (en) * 1991-10-18 1993-04-29 Alza Corporation Device for the transdermal administration of melatonin
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
ES2137261T3 (es) * 1992-05-13 1999-12-16 Alza Corp Administracion transdermica de oxibutinina.
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
DE69401945T3 (de) * 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
US7027859B1 (en) * 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
DE69512083T2 (de) 1994-11-17 2000-03-30 Alza Corp Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
US5843014A (en) * 1995-03-24 1998-12-01 Alza Corporation Display for an electrotransport delivery device
US6425892B2 (en) * 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
KR100449943B1 (ko) * 1995-06-05 2004-12-03 알자 코포레이션 펜타닐및서펜타닐의경피투여를위한일렉트로트랜스포트장치및그의제조방법
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
US5667799A (en) * 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
US6660295B2 (en) 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
EP1911488A3 (de) 1997-12-11 2008-12-03 Alza Corporation Vorrichtung zur Verstärkung des Flusses transdermaler Mittel
JP2001525227A (ja) 1997-12-11 2001-12-11 アルザ・コーポレーション 経皮的薬剤流量を高めるための装置
KR100561892B1 (ko) * 1997-12-11 2006-03-16 알자 코포레이션 경피성 작용제 유동률을 증진시키기 위한 장치
CN1161164C (zh) * 1997-12-11 2004-08-11 阿尔扎有限公司 用于通过体表导入或提取质剂的装置
ES2182379T3 (es) * 1997-12-22 2003-03-01 Alza Corp Membrana de regulacion del regimen de liberacion para dispositivos de administracion controlada de farmacos.
US6103771A (en) * 1998-03-20 2000-08-15 Caldwell Galer Incorporated Method of treating neuroma pain
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US6858018B1 (en) 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
US6348210B1 (en) 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE69941629D1 (de) 1998-12-18 2009-12-17 Alza Corp Durchsichtige transdermale nicotinabgabevorrichtungen
GB9828480D0 (en) * 1998-12-24 1999-02-17 Dermatech Limited Transdermal drug delivery system
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
EP1867348B1 (de) * 1999-03-25 2012-05-16 Metabolix, Inc. Medizinische Geräte und Anwendungen aus Polyhydroxyalkanoat-Polymeren
EP1169025B1 (de) * 1999-04-01 2005-08-24 Alza Corporation Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir
JP2003508425A (ja) 1999-08-30 2003-03-04 テファ, インコーポレイテッド 洗浄可能な使い捨てポリマー製品
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
KR20010036685A (ko) 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
WO2001041863A1 (en) 1999-12-10 2001-06-14 Alza Corporation Device and method for enhancing microprotrusion skin piercing
ES2312413T3 (es) 2000-02-08 2009-03-01 Euro-Celtique S.A. Composiciones de liberacion controlada que contienen un agonista y antagonista de opioide.
JP4969009B2 (ja) * 2000-03-10 2012-07-04 ダレクト コーポレーション オピオイド製剤
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
CN101181241A (zh) * 2000-07-31 2008-05-21 尼科梅德丹麦股份有限公司 用于鼻内给药的芬太尼组合物
JP2004509222A (ja) * 2000-09-19 2004-03-25 ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション 経皮薬物送達システムにおいて有用な非反応型接着剤
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
EP1757280A1 (de) 2001-03-16 2007-02-28 ALZA Corporation Transdermales Pflaster zur Verabreichung von Sufentanyl
JP5354763B2 (ja) * 2001-03-16 2013-11-27 アルザ・コーポレーシヨン フェンタニルを投与するための経皮的張り付け剤
DE60228294D1 (de) * 2001-06-05 2008-09-25 Ronald Aung-Din Topische migränetherapie
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
WO2003015678A1 (en) 2001-08-17 2003-02-27 Lavipharm Laboratories Inc. Composition and transdermal drug delivery device
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
KR100844312B1 (ko) 2001-09-06 2008-07-07 노사케미컬(주) 펜타닐 경피 투여 제제
CN101406703A (zh) 2002-04-23 2009-04-15 阿尔扎公司 降低了滥用可能的经皮止痛系统
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
CN1655772B (zh) * 2002-05-28 2010-05-26 拉伯泰克技术研发有限公司 含有芬太尼的贴剂
DE10223835A1 (de) 2002-05-28 2003-12-11 Labtec Gmbh Pflaster, enthaltend Fentanylum
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
DK1513532T3 (da) 2002-06-10 2007-07-02 Euro Celtique Sa Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US20040202704A1 (en) * 2002-08-30 2004-10-14 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods
JP4758101B2 (ja) * 2002-09-13 2011-08-24 久光製薬株式会社 貼付剤
WO2004026283A1 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sequestering subunit and related compositions and metohds
JP4542429B2 (ja) * 2002-10-18 2010-09-15 久光製薬株式会社 フェンタニル経皮外用貼付剤
WO2004039317A3 (en) * 2002-10-25 2004-09-23 Peter Boer Analogs and prodrugs of buprenorphine
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
US20060078600A1 (en) * 2003-02-07 2006-04-13 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
US20060062812A1 (en) * 2003-03-11 2006-03-23 Calvin Ross Novel compositions
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
US7834147B2 (en) * 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
EP2860292A3 (de) 2003-05-08 2015-10-14 Tepha, Inc. Medizinische Polyhydroxyalkanoattextilien und -fasern
JP5137286B2 (ja) 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
WO2004112723A3 (en) 2003-06-20 2005-07-28 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
JP2007528853A (ja) * 2003-07-08 2007-10-18 テファ, インコーポレイテッド 徐放性薬物送達のためのポリ−4−ヒドロキシブチレートマトリックス
US8524272B2 (en) 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
JP2007503221A (ja) * 2003-08-22 2007-02-22 テファ, インコーポレイテッド ポリヒドロキシアルカノエート神経再生デバイス
CN1909892A (zh) 2003-10-30 2007-02-07 阿尔扎公司 具有降低的滥用可能性的透皮止痛剂系统
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
KR100789227B1 (ko) 2004-02-23 2007-01-09 유로-셀띠끄 소시에떼 아노님 남용 방지 오피오이드 경피 전달 장치
WO2005105009A1 (en) * 2004-04-26 2005-11-10 Cassel Douglas R Wound treatment patch for alleviating pain
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
EP1778305B1 (de) * 2004-08-03 2010-07-07 Tepha, Inc. Nichtkräuselnde polyhydroxyalkanoatnähte
JP4745747B2 (ja) * 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
JP4824963B2 (ja) * 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
DK1814531T3 (da) * 2004-10-21 2010-10-11 Durect Corp Transdermale leveringssystemer
US8252319B2 (en) * 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US20060177513A1 (en) * 2005-01-28 2006-08-10 Tepha, Inc. Embolization using poly-4-hydroxybutyrate particles
RU2007135188A (ru) * 2005-02-24 2009-03-27 Алза Корпорейшн (Us) Трансдермальные электротранспортные системы доставки лекарственного препарата со сниженной возможностью злоупотребления
US7309809B2 (en) * 2005-02-26 2007-12-18 Xennovate Medical Llc Adhesive attachment and removal device
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
US7686820B2 (en) * 2005-04-14 2010-03-30 Ethicon Endo-Surgery, Inc. Surgical clip applier ratchet mechanism
US8523882B2 (en) 2005-04-14 2013-09-03 Ethicon Endo-Surgery, Inc. Clip advancer mechanism with alignment features
US7288098B2 (en) 2005-04-14 2007-10-30 Ethicon Endo-Surgery, Inc. Force limiting mechanism for medical instrument
US7740641B2 (en) * 2005-04-14 2010-06-22 Ethicon Endo-Surgery, Inc. Clip applier with migrational resistance features
US8038686B2 (en) 2005-04-14 2011-10-18 Ethicon Endo-Surgery, Inc. Clip applier configured to prevent clip fallout
US7261724B2 (en) 2005-04-14 2007-08-28 Ethicon Endo-Surgery, Inc. Surgical clip advancement mechanism
US7297149B2 (en) * 2005-04-14 2007-11-20 Ethicon Endo-Surgery, Inc. Surgical clip applier methods
DE602006016441D1 (de) * 2005-05-13 2010-10-07 Alza Corp Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
US20090143761A1 (en) * 2005-06-03 2009-06-04 Transdermal Patents Company, Llc Agent delivery system and uses of same
EP1893278A2 (de) * 2005-06-03 2008-03-05 Trans-Dermal Patents Company, LLC System zur abgabe eines arzneimittels
WO2007035941A3 (en) * 2005-09-23 2007-05-18 Alza Corp Transdermal galantamine delivery system
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
EP1948142B1 (de) * 2005-09-23 2014-04-09 ALZA Corporation Polyacrylatformulierung mit hoher beladung von verstärkenden substanzen für transdermale anwendungen
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US7888422B2 (en) * 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
JP2009516718A (ja) * 2005-11-23 2009-04-23 ウニベルジテート チューリッヒ 経皮アレルゲン投与によるアレルギー治療
JP2009528990A (ja) * 2006-02-13 2009-08-13 アヴィバ ドラッグ デリバリー システムズ スフェンタニルを含む接着性調製物およびそれを用いる方法
KR20090021169A (ko) * 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 R(+) 및 s(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US8518926B2 (en) * 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
US20070248657A1 (en) * 2006-04-25 2007-10-25 Smith David J Multi-compartment transdermal pain control device
EP2020988B1 (de) 2006-04-28 2017-08-16 Children's Hospital Medical Center Zusammensetzungen mit fusogenen proteinen oder polypeptiden aus prosaposin zur anwendung auf transmembrane wirkstofffreisetzungssysteme
US20070278289A1 (en) * 2006-05-31 2007-12-06 Toshiba Tec Kabushiki Kaisha Payment adjusting apparatus and program therefor
ES2636657T3 (es) * 2006-06-19 2017-10-06 Alpharma Pharmaceuticals Llc Composición farmacéutica
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US8647664B2 (en) * 2006-07-14 2014-02-11 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ,インコーポレイテッド 医薬組成物
WO2008066642A3 (en) * 2006-11-03 2009-04-30 Durect Corp Transdermal delivery systems comprising bupivacaine
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
CN101715443A (zh) * 2007-03-14 2010-05-26 诺普神经科学股份有限公司 手性纯化的取代的苯并噻唑二胺的合成
JP5451613B2 (ja) 2007-08-06 2014-03-26 アラーガン、インコーポレイテッドAllergan,Incorporated デスモプレシン薬物送達のための方法及びデバイス
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
JP5687901B2 (ja) 2007-10-15 2015-03-25 アルザ・コーポレーシヨン 日に1回の取り替えによるフェンタニルの経皮投与
EP2235171A1 (de) * 2007-12-12 2010-10-06 Aarhus Universitet (University Of Aarhus) Kristallstruktur einer plasmamembran-protonenpumpe
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8124126B2 (en) 2008-01-09 2012-02-28 Charleston Laboratories, Inc. Pharmaceutical compositions
KR20100116186A (ko) * 2008-01-28 2010-10-29 데이고꾸세이약꾸가부시끼가이샤 펜타닐 함유 외용 패치
EP2111857A1 (de) * 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
EP2296686B2 (de) * 2008-05-21 2017-11-01 Ferring B.V. Oral dispergierbares desmopressing zur verlängerung der anfangsschlafphase ohne störung durch nocturie
WO2009140972A3 (en) 2008-05-22 2010-06-17 H. Lundbeck A/S Modulation of the vps10p-domain receptors for the treatment of cardiovascular disease
WO2009155932A3 (en) 2008-06-25 2010-04-22 H. Lundbeck A/S Modulation of the trpv : vps10p-domain receptor system for the treatment of pain
US8592424B2 (en) 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
KR20110071064A (ko) * 2008-08-19 2011-06-28 크놉 뉴로사이언시스 인코포레이티드 (r)-프라미펙솔을 사용하는 조성물 및 방법
ES2529586T3 (es) 2008-09-12 2015-02-23 Pharma Gp Aps Composición de calostro
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
EP2379593A2 (de) 2008-12-19 2011-10-26 H. Lundbeck A/S Modulation der vps-10-domänenrezeptorfamilie zur behandlung von geistes- und verhaltensstörungen
WO2010095537A1 (ja) * 2009-02-18 2010-08-26 久光製薬株式会社 経皮吸収製剤
CA2765876A1 (en) * 2009-06-19 2010-12-23 Knopp Neurosciences, Inc. Compositions and methods for treating amyotrophic lateral sclerosis
EP2451274B1 (de) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
EP2295046B1 (de) 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US8262679B2 (en) 2009-10-09 2012-09-11 Ethicon Endo-Surgery, Inc. Clip advancer
US8267945B2 (en) 2009-10-09 2012-09-18 Ethicon Endo-Surgery, Inc. Clip advancer with lockout mechanism
DE102009048973A1 (de) * 2009-10-09 2011-04-14 Beiersdorf Ag Transdermale therapeutische Systeme enthaltend 4-n-Butylresorcin
US9588121B2 (en) 2009-11-06 2017-03-07 Go Therapeutics, Inc. Method for early detection of cancer
WO2011095174A1 (en) 2010-02-08 2011-08-11 Aarhus Universitet Human herpes virus 6 and 7 u20 polypeptide and polynucleotides for use as a medicament or diagnosticum
WO2011107100A1 (en) 2010-03-03 2011-09-09 Aarhus Universitet Methods and compositions for regulation of herv4
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
CA2796965A1 (en) 2010-04-28 2012-04-12 Kimberly-Clark Worldwide, Inc. Method for increasing permeability of an epithelial barrier
CN102971037B (zh) 2010-04-28 2016-05-25 金伯利-克拉克环球有限公司 用于递送类风湿性关节炎药物的装置
KR101794376B1 (ko) 2010-04-28 2017-11-06 킴벌리-클라크 월드와이드, 인크. siRNA 전달용 의료 기구
US20130115212A1 (en) 2010-06-14 2013-05-09 Lundbeck A/S Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors
ES2643291T3 (es) 2010-12-22 2017-11-22 Purdue Pharma L.P. Formas de dosificación de liberación controlada con cierre inviolable recubiertas
CA2822769C (en) 2010-12-23 2016-10-04 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
US8696637B2 (en) 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
US9731121B2 (en) 2011-03-31 2017-08-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8781571B2 (en) 2011-03-31 2014-07-15 Incline Therapeutics, Inc. Switch validation circuit and method
EP2759294B1 (de) 2011-09-22 2017-11-01 Samyang Biopharmaceuticals Corporation Perkutan absorbierbares präparat mit fentanyl und einem homolog davon
KR20140067042A (ko) 2011-09-30 2014-06-03 테이코쿠 팔마 유에스에이, 인코포레이티드 일반 약물 처리 시스템
WO2013049380A1 (en) 2011-09-30 2013-04-04 Teikoku Pharma Usa, Inc. Transdermal patch disposal system
WO2013059432A1 (en) 2011-10-19 2013-04-25 Ethicon Endo-Surgery, Inc. Clip applier adapted for use with a surgical robot
EP2599478A1 (de) 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9869499B2 (en) 2012-02-10 2018-01-16 Carrier Corporation Method for detection of loss of refrigerant
US8946253B2 (en) 2012-04-17 2015-02-03 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
US20150133383A1 (en) 2012-05-11 2015-05-14 Prorec Bio Ab Method for diagnosis and treatment of prolactin associated disorders
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
JP6208261B2 (ja) 2013-02-05 2017-10-04 パーデュー、ファーマ、リミテッド、パートナーシップPurdue Pharma L.P. タンパリング抵抗性医薬製剤
EP2953628A1 (de) 2013-02-11 2015-12-16 Glycanova AS Creme aus basidiomyceten zur behandlung von hauterkrankungen
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
CN105163719A (zh) 2013-03-11 2015-12-16 度瑞公司 包含高粘度液体载体的可注射控制释放组合物
US20140271896A1 (en) 2013-03-15 2014-09-18 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
EP2999444A4 (de) 2013-05-20 2016-10-12 Mylan Inc Erweiterte transdermale dosierung von pramipexol zur behandlung von neurologischen erkrankungen
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
WO2015023790A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
JP2016536326A (ja) 2013-08-29 2016-11-24 ユニバーシティ オブ コペンハーゲン 癌治療用抗adam12抗体
US9849124B2 (en) 2014-10-17 2017-12-26 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL107185C (de) * 1957-12-19
US3742951B1 (de) * 1971-08-09 1982-11-23
GB1511121A (en) * 1975-02-06 1978-05-17 Alza Corp Administration of scopolamine
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4127127A (en) * 1977-05-23 1978-11-28 Alza Corporation Therapeutic systems made from certain segmented copolyesters
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPH0121128B2 (de) * 1979-01-11 1989-04-19 Key Pharma
US4379789A (en) * 1979-12-17 1983-04-12 Ortho Pharmaceutical Corporation Analgesic composition
JPS5919926B2 (de) * 1980-01-16 1984-05-09 Nitto Electric Ind Co
JPS5714522A (en) * 1980-06-09 1982-01-25 Key Pharma Polymer diffused matrix
JPS57123117A (en) * 1981-01-23 1982-07-31 Nitto Electric Ind Co Ltd Administration of drug from adhesive preparation
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS6059207B2 (de) * 1981-03-13 1985-12-24 Nitto Electric Ind Co
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
JPS5919926A (en) * 1982-07-27 1984-02-01 Canon Inc Vari-focal camera
US4486423A (en) * 1983-04-21 1984-12-04 Janssen Pharmaceutica Inc. Stable fentanyl composition
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
JPH0425928B2 (de) * 1984-03-05 1992-05-06 Nitto Denko Corp
ES2075966T3 (es) * 1986-12-22 1995-10-16 Cygnus Therapeutic Systems Dispositivo de suministro de medicamentos solidos que utilizan esteres de acidos grasos o eteres de alcoholes grasos de alcanodioles como potenciadores de absorcion percutanea.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHIEN, Y.W.: Novel Drug Derivery System - Fun- damentals, Development Concepts, Biomedical Assessments, New York, Marcel Dekker, Inc. 1982, Kap. 5, Transdermal Control-Release Drug Adminis- tration, S. 168-170 *
MICHAELS, A.S. et al.: AICHE Journal, 21, 5, S. 985-996, 1975 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839410A1 (de) * 1987-11-23 1989-06-01 Alza Corp Mittel zur transdermalen verabreichung von wirkstoffen
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6231886B1 (en) 1997-02-24 2001-05-15 Robert F. Reder Methods of providing sustained treatment with opioids
US6344212B2 (en) 1997-02-24 2002-02-05 Euro-Celtique S.A. Method of providing sustained analgesia with buprenorphine
USRE41408E1 (en) 1997-02-24 2010-06-29 Purdue Pharma L.P. Method of providing sustained analgesia with buprenorpine
USRE41489E1 (en) 1997-02-24 2010-08-10 Purdue Pharma L.P. Method of providing sustained analgesia with buprenorphine
USRE41571E1 (en) 1997-02-24 2010-08-24 Purdue Pharma L.P. Method of providing sustained analgesia with buprenorphine
US9642850B2 (en) 1997-02-24 2017-05-09 Purdue Pharma L.P. Method of providing sustained analgesia with buprenorphine
US8778382B2 (en) 2003-04-30 2014-07-15 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form

Also Published As

Publication number Publication date Type
DE3526339C2 (de) 1992-01-09 grant
FR2567761A1 (fr) 1986-01-24 application
NL8501979A (nl) 1986-02-17 application
ES545366D0 (de) grant
BE905568R (fr) 1987-02-02 grant
ES8707667A1 (es) 1987-11-01 application
GB2165148A (en) 1986-04-09 application
ES557179A0 (es) 1987-08-16 application
BE902884A1 (de) grant
BE902884A (fr) 1985-11-04 grant
ES545366A0 (es) 1988-05-01 application
US4588580B2 (en) 1999-02-16 grant
FR2567761B1 (fr) 1988-12-02 grant
ES557179D0 (de) grant
JPS6137725A (en) 1986-02-22 application
BE905568A4 (de) grant
JP2547726B2 (ja) 1996-10-23 grant
US4588580A (en) 1986-05-13 grant
ES8802276A1 (es) 1988-07-16 application
GB8514445D0 (en) 1985-07-10 grant
CA1245983A (en) 1988-12-06 grant
CA1245983A1 (de) grant
US4588580B1 (de) 1989-01-03 grant
GB2165148B (en) 1989-05-17 grant

Similar Documents

Publication Publication Date Title
FR2585252B1 (fr) Pousse-seringue
DE3536669A1 (de) Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten
DE3609054A1 (de) Spritzgusssystem
DE3508319A1 (de) Blockierschutzbrems- und antriebsschlupfschutzanlage
DE3500508A1 (de) Praeparat zur perkutanen verabreichung von arzneimitteln und verfahren zu dessen herstellung
DE3333240A1 (de) Mittel zur transdermalen applikation von arzneimittelwirkstoffen
DE3428655A1 (de) Spritzenpumpe
DE3503354A1 (de) Wirkstoff-spender
DE3347278A1 (de) Wirkstoffabgabesysteme
DE3526339A1 (de) Transdermales abgabesystem zur verabreichung von fentanyl
DE3613007A1 (de) System zur ermittlung von nicht-abgerechneten drucken
DE3518462A1 (de) System zur verschluesselten nachrichtenuebertragung
DE69026837T2 (de) Transdermales system
DE69422073T2 (de) Vorrichtung für subkutane Verabreichung von Medikamenten
DE3429038A1 (de) Wirkstoff-depot
DE8504357U1 (de) Epicondylitis-bandage
DE3507024A1 (de) Loesung zur augenbehandlung
DE3612644A1 (de) Einspritzvorrichtung
DE3501410A1 (de) Verfahren zum auftragen von lot
DE3416719A1 (de) Einrichtung zur automatisch regelbaren entlastung von flugzeugtragflaechen
DE3129995A1 (de) Verfahren zur beschleunigung des aufloesens von schwerloeslichen lyophilisierten arzneimitteln
DE8425039U1 (de) Staender zur praesentation von verkaufsguetern o. dgl.
DE3513938A1 (de) Cytostatikahaltiges pharmakadepot
DE3413540A1 (de) Uebertragungsgeraet fuer medikamentenwirkung
DE3523065A1 (de) Therapeutisches abgabesystem

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: BARDEHLE, H., DIPL.-ING. DOST, W., DIPL.-CHEM. DR.

8125 Change of the main classification

Ipc: A61L 15/03

Q171 Divided out to:

Ref country code: DE

Ref document number: 3546818

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3546818

Format of ref document f/p: P

Q171 Divided out to:

Ref document number: 3546830

Ref country code: DE

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3546830

Format of ref document f/p: P

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 3546830

Format of ref document f/p: P

8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 3546830

Format of ref document f/p: P